HPV vaccines: their pathology-based discovery, benefits, and adverse effects-Reference-Cited by-同舟云学术

HPV vaccines: their pathology-based discovery, benefits, and adverse effects

Published:2015-12 Issue:6 Volume:19 Page:418-422
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Nicol Alcina F.,de Andrade Cecilia V.,Russomano Fabio B.,Rodrigues Luana S.L.,Oliveira Nathalia S.,Provance David William,Nuovo Gerard J.

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference23 articles.

1. Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States—2008-2012;Hariri;Vaccine,2015

2. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial;Paavonen;Lancet,2007

3. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials;Joura;Lancet,2007

4. National and state vaccination coverage among adolescents aged 13-17 years—United States (2012);Centers for Disease Control and Prevention;MMWR,2013

5. Fall in human papillomavirus prevalence following a national vaccination program;Tabrizi;J Infect Dis,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Berries vs. Disease: Revenge of the Phytochemicals;Pharmaceuticals;2024-01-09

2. Current status and challenges of immunotherapy in ALK rearranged NSCLC;Frontiers in Oncology;2022-12-14

3. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using Mus musculus Papillomavirus;Viruses;2022-05-08

4. The Efficacy and Safety of Continuous Intravenous Endostar Treatment Combined With Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: A Randomized Controlled Trial;Frontiers in Oncology;2021-08-13

5. Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches;Cancers;2021-03-23